Similar Articles
881 Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
882 Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study
883 Systemic treatment for hepatocellular carcinoma: Still unmet expectations
884 Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
885 Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma
886 Disease monitoring of hepatocellular carcinoma through metabolomics
887 Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
888 How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
889 Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
890 Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA